Lun Zeng
Chief Executive Officer at Guangdong Xiangxue Precision Medical Technology Co., Ltd.
Profile
Lun Zeng currently works at Guangzhou Xiangxue Bio-medical Eng Co., Ltd., as Chairman & General Manager and Guangdong Xiangxue Precision Medical Technology Co., Ltd., as Chairman & General Manager.
Lun Zeng active positions
Companies | Position | Start |
---|---|---|
Guangdong Xiangxue Precision Medical Technology Co., Ltd.
Guangdong Xiangxue Precision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Guangdong Xiangxue Precision Medical Technology Co., Ltd. engages in TCR-based therapies for cancer. It provides research and development services, including large scale GMP grade lentivirus production, target identification and lead optimization, efficacy validation and safety testing in cell lines and animal models, clinical trial development, and market entry planning. The company was founded on November 12, 2015 and is headquartered in Guangzhou, China. | Chief Executive Officer | - |
Guangzhou Xiangxue Bio-medical Eng Co., Ltd.
Guangzhou Xiangxue Bio-medical Eng Co., Ltd. BiotechnologyHealth Technology Part of Gortune Investment Co., Ltd., Guangzhou Xiangxue Bio-medical Eng Co., Ltd. is a bio medical company. The company is based in Guangzhou, China. Guangzhou Xiangxue Bio-medical Eng Co. was acquired by Yuemin Investment Guangzhou Financial Invt Co., Ltd. from Xiangxue Pharmaceutical Co., Ltd. on December 06, 2021 for $2.83 million. The Chinese company was founded in 2000. The CEO is Lun Zeng. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Guangzhou Xiangxue Bio-medical Eng Co., Ltd.
Guangzhou Xiangxue Bio-medical Eng Co., Ltd. BiotechnologyHealth Technology Part of Gortune Investment Co., Ltd., Guangzhou Xiangxue Bio-medical Eng Co., Ltd. is a bio medical company. The company is based in Guangzhou, China. Guangzhou Xiangxue Bio-medical Eng Co. was acquired by Yuemin Investment Guangzhou Financial Invt Co., Ltd. from Xiangxue Pharmaceutical Co., Ltd. on December 06, 2021 for $2.83 million. The Chinese company was founded in 2000. The CEO is Lun Zeng. | Health Technology |
Guangdong Xiangxue Precision Medical Technology Co., Ltd.
Guangdong Xiangxue Precision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Guangdong Xiangxue Precision Medical Technology Co., Ltd. engages in TCR-based therapies for cancer. It provides research and development services, including large scale GMP grade lentivirus production, target identification and lead optimization, efficacy validation and safety testing in cell lines and animal models, clinical trial development, and market entry planning. The company was founded on November 12, 2015 and is headquartered in Guangzhou, China. | Technology Services |
- Stock Market
- Insiders
- Lun Zeng